CME Course: FDA Draft Guidance on Platelet Safety

Platelets play a vital role for all transfusion services. However there are risks associated with their use, in particular the possibility of bacterial contamination. In light of this, in March of 2016 the FDA released draft Guidance proposing measures to increase platelet safety. This course provides an overview of the Guidance and highlights some of the challenges to implementation.

TARGET AUDIENCE/PREREQUISITES
This activity has been designed for general, specialty and subspecialty physicians who prescribe blood products and for hospital transfusion service medical directors. There are no participant prerequisites for this activity.

Continuing Certification Category: Medical Knowledge

Enter Course

LEARNING OBJECTIVES
At the conclusion of this activity, participants should be able to:

  1. Be familiar with the significant elements of the draft Guidance.
  2. Identify the challenges in implementing the suggested process changes.
  3. Discuss how the final Guidance may appear after public comments have been submitted.

LEARNING TASKS
To receive CME credit for this activity, participants must:

  1. Acknowledge their review of activity prerequisites, objectives, disclosures, methods of physician participation and statements.
  2. Review the presentation "Indications for Blood Transfusion" or review the slides and accompanying notes available as a printable Adobe Reader® file.
  3. Take the online Post-Test.
  4. Complete the online Activity Evaluation.
  5. Print the certificate awarding 1.0 AMA PRA Category 1 credit(s)TM through the SUCCESSTM program.

FACULTY
Catherine Mazzei, MD
Medical Director, Northern California Region
American Red Cross

ACTIVITY PLANNER
Catherine Mazzei, MD
Medical Director, Northern California Region
American Red Cross


LEARNING REFERENCES

Listed in the presentation.

DISCLOSURES
Activity faculty and planners have indicated that they have no relevant financial relationships with commercial interests to disclose. No commercial support was received for this activity.

DISCLAIMER
The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of the American Red Cross Biomedical Services. Information herein is presented for educational purposes only and not to endorse off-label use. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

ACCREDITATION STATEMENT
The American Red Cross Biomedical Services (ARCBS) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This activity meets the American Board of Pathology (ABP) Continuation of Certifiation (MOC) for Self-Assessment Modules (SAMs).

DESIGNATION STATEMENT
The American Red Cross Biomedical Services designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™; physicians should only claim credit commensurate with the extent of their participation in the activity.

PASSING REQUIREMENTS
If you correctly answer 75% or more of the post-test items you may claim credit. CME/SAM credit can be applied to the American Board of Pathology (ABP) Self-Assessment Module (SAM) requirements.

DISCLOSURE STATEMENT
All faculty participating in ARCBS continuing medical education programs are expected to disclose to learners whether they do or do not have any real or apparent conflict(s) of interest or other relationships related to the content of their presentation(s); faculty are also expected to disclose off-label and/or investigational uses of products under discussion.

RELEASE DATE: 07/31/2017

EXPIRATION DATE: 07/30/2020

ESTIMATED TIME TO COMPLETE ACTIVITY: 1.0 hour(s)

This activity has been designed for general, specialty, and subspecialty physicians who prescribe blood products, care for blood donors or have related interests. There are no participant prerequisites for this activity.

CME CREDITS:
1.0 AMA PRA Category 1 Credit(s) TM
Last modified: Tuesday, June 5, 2018, 03:25 PM